• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Infect Dis Rep . SARS-CoV-2 Variants of Concern and Clinical Severity in the Mexican Pediatric Population

tetano

Editor, Senior Moderator
Infect Dis Rep


. 2023 Sep 11;15(5):535-548.
doi: 10.3390/idr15050053. SARS-CoV-2 Variants of Concern and Clinical Severity in the Mexican Pediatric Population

Anahí Maldonado-Cabrera[SUP] 1 2 [/SUP], Jesus Alejandro Colin-Vilchis[SUP] 3 [/SUP], Ubydul Haque[SUP] 4 5 [/SUP], Carlos Velazquez[SUP] 1 [/SUP], Andrea Socorro Alvarez Villaseñor[SUP] 6 [/SUP], Luis Eduardo Magdaleno-Márquez[SUP] 7 [/SUP], Carlos Iván Calleros-Muñoz[SUP] 8 [/SUP], Karen Fernanda Figueroa-Enríquez[SUP] 8 [/SUP], Aracely Angulo-Molina[SUP] 1 9 [/SUP], Ana Lucía Gallego-Hernández[SUP] 1 [/SUP]



Affiliations
Abstract

The emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants of concern (VOCs) presents global heterogeneity, and their relative effect on pediatric severity is still limited. In this study, we associate VOCs with pediatric clinical severity outcomes in Mexico. Bioinformatics methods were used to characterize VOCs and single amino acid (aa) mutations in 75,348 SARS-CoV-2 genetic sequences from February 2020 to October 2022. High-predominance VOCs groups were calculated and subsequently associated with 372,989 COVID-19 clinical pediatric outcomes. We identified 21 high-frequency mutations related to Omicron lineages with an increased prevalence in pediatric sequences compared to adults. Alpha and the other lineages had a significant increase in case fatality rate (CFR), intensive critical unit (ICU) admission, and automated mechanical ventilation (AMV). Furthermore, a logistic model with age-adjusted variables estimated an increased risk of hospitalization, ICU/AMV, and death in Gamma and Alpha, in contrast to the other lineages. We found that, regardless of the VOCs lineage, infant patients presented the worst severity prognoses. Our findings improve the understanding of the impact of VOCs on pediatric patients across time, regions, and clinical outcomes. Enhanced understanding of the pediatric severity for VOCs would enable the development and improvement of public health strategies worldwide.

Keywords: COVID-19; children; hospitalization; mortality; pediatrics; severity.

 
Back
Top Bottom